- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 513/20 - Spiro-condensed systems
Patent holdings for IPC class C07D 513/20
Total number of patents in this class: 109
10-year publication summary
|
9
|
3
|
1
|
6
|
10
|
8
|
17
|
7
|
8
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Amgen Inc. | 4425 |
13 |
| Janssen Pharmaceutica N.V. | 3171 |
8 |
| Gilead Sciences, Inc. | 2220 |
7 |
| Novartis AG | 10263 |
5 |
| Erasca, Inc. | 98 |
4 |
| Merck Sharp & Dohme LLC | 3735 |
4 |
| The Regents of the University of Michigan | 4979 |
3 |
| Biogen MA Inc. | 937 |
3 |
| The Broad Institute, Inc. | 1975 |
3 |
| Chugai Seiyaku Kabushiki Kaisha | 1422 |
3 |
| Jazz Pharmaceuticals Ireland Limited | 172 |
3 |
| Aranda Pharma Ltd | 5 |
2 |
| Janssen Sciences Ireland UC | 158 |
2 |
| Ascentage Pharma (Suzhou) Co., Ltd. | 227 |
2 |
| Ascentage Pharma Group Corp Limited | 149 |
2 |
| Avelos Therapeutics, Inc. | 17 |
2 |
| Fundação GIMM - Gulbenkian Institute for Molecular Medicine | 22 |
2 |
| LG Chem, Ltd. | 17921 |
1 |
| Genentech, Inc. | 4099 |
1 |
| Pfizer Inc. | 3384 |
1 |
| Other owners | 38 |